2021 IEOC/an-vision, Inc. Equine Ophthalmology Consortium

725
802

 


an-vision, Inc./IEOC Equine
Ophthalmology Consortium Symposium

The 2021 IEOC symposium schedule and has been modified to accommodate a virtual format. Our Keynote presenters have generously agreed to pre-record their lectures, then attend a live question and answer session as per the published schedule shown below. 

Courses are pre-recorded and will be available on-demand, for 24 hour access beginning end of day June 4th. Registrants should expect to receive an email with sign-in information, proceedings notes pdf link and instructons by 5pm Mountain Time USA on June 4th. Preview all presentations and develop your questions soon!  We have also asked those presenting case reports and abstracts to be availble for questions during their group time slots shown below.

Registraton will be open through mid-June, but registrants who wish to attend the live Q&A sessions with speakers must register by end of day June 9th to gain live access.

Register here today!



Schedule

Live Q&A Sessions: These will be attended by the speakers on the schedule. IEOC plans to also record these sessions and make them availble to attendees through June.

FRIDAY, JUNE 11TH Eastern Time:

9:50am - 10:00am LOG IN
10:00am - 10:05am WELCOME, THANKS an-vision, INTRODUCE SPEAKER
10:05am - 10:40am KEYNOTE HOPKINSON: Q&A discussions
10:40am - 10:45am  BREAK
10:45am INTRODUCE SPEAKER
10:45am - 11:15am KEYNOTE HECTOR: Q&A discussions
11:15am - 11:20am BREAK
11:20am INTRODUCE SPEAKER
11:20am - 11:50am KEYNOTE MILLER: Q&A discussions
11:50am - 12:00pm MEETING CLOSE & THANKS
   


SATURDAY, JUNE 12TH Eastern Time:

9:50am - 10:00am LOG IN
10:00am - 10:05am WELCOME, THANKS an-vision, INTRODUCE SESSION
10:05am - 10:50am CASE REPORTS: Q&A discussions
10:50am - 10:55am  BREAK
10:55am INTRODUCE SESSION
10:55am - 11:40am ABSTRACTS: Q&A discussions
11:40am MEETING CLOSE & THANKS
11:40am - 11:50am  BREAK
11:50am - 12:20pm  MEMBERSHIP MEETING: Zoom  (separate link emailed with agenda to members only)


Keynote Speakers

808 Paul E. Miller, DVM, DACVO
Clinical Professor of Comparative Ophthalmology
School of Veterinary Medicine
University of Wisconsin-Madison


Biography:
Dr. Miller is a Clinical Professor of Comparative Ophthalmology at the School of Veterinary Medicine, University of Wisconsin-Madison and a Diplomate of the American College of Veterinary Ophthalmologists. He is a former President of the American College of Veterinary Ophthalmologists and also serves on the editorial board for the journal Veterinary Ophthalmology.  He main research interests are glaucoma, the visual capabilities of animals, and ocular toxicology.  He has given over 450 scientific and continuing education presentations, authored more than 170 scientific publications, and edits the textbook Fundamentals of Veterinary Ophthalmology with Drs. David Maggs and Ron Ofri.  He also created and edited several editions of Ophthalmology Section of the Five Minute Veterinary Consult.

Lecture title:
“Vision in Horses:  What Do They See?”
The fundamental components of vision and visual perception in horses will be reviewed.  The discussion will cover how visual attention, luminance, visual orientation, movement, depth perception, field of view, visual acuity and color perception impact the visual world of horses.  We will also touch on why the clinician should optimize their therapeutic choices with the goal of maintaining the full scope of the patient’s visual abilities and not simply be satisfied that their patient responds to a menacing gesture and does not bump into objects.



809 Rachel Hector, DVM, MS, DACVAA
Clinical Instructor, Anesthesiology
Veterinary Teaching Hospital
Colorado State University 

Biography:
Growing up all over the world, one thing was a constant in my life: animals of all kinds and the desire to become a veterinarian. I could be counted on to befriend the neighborhood cats and spend more time at a party getting to know the resident dog than anyone else. I spent years working with abused and neglected horses and owned and trained horses throughout my undergraduate studies in animal sciences and subsequently veterinary school at Oregon State University. Early on in my veterinary education, I knew that I wanted to pursue specialty training because I wanted to keep learning and innovating after graduation - at first I just didn't know which specialty to choose. After veterinary school, I worked at an equine surgical referral practice outside of Vancouver, British Columbia for two years prior to completing a residency and board certification in veterinary anesthesiology at Colorado State University in 2017. My favorite thing about anesthesia is that it combines aspects of all specialties. To do it well, one must understand surgery, oncology, internal medicine, cardiology, and pharmacology to name a few. For someone with an interest in just about everything, anesthesia is the ultimate specialty. Although I love working on all species, my area of expertise and research focus is primarily equine. Some of my particular interests include equine post-operative pain management, improving anesthetic recovery safety, behavior and handling of nervous and frightened horses in a hospital setting, and anesthetic management of horses with colic and endotoxemia.

Lecture Title:
"Using Positive Reinforcement Training to Facilitate

Ophthalmologic Procedures and a Review of Standing Sedation
Strategies for Ophthalmologic Procedures"

 

812 Andrew Hopkinson, PhD
Founder and Chief Scientific Officer
NuVision Biotherapies

Andrew Hopkinson, PhD, is the Chief Scientific Officer, founder and visionary of NuVision and Honorary Ass. Professor University of Nottingham.  Andrew has 18 years translational research expertise in ophthalmic regenerative medicine at University of Nottingham Centre For Eye research, which is part of Academic Ophthalmology, Division of Clinical Neurosciences. During his time at the University, he and his multidisciplinary research team have been engaged in developing advanced therapies to repair and regenerate injured ocular surface for visual rehabilitation.

One of his main aspects of research was focused on understanding the biochemical, biological and functional properties of amniotic membrane with the aim of improving its quality and clinical efficacy for ophthalmic and wound care application. His research pioneered the development of the Tereo manufacture process which is used to produce Omnigen.

Andrew continues to drive ground-breaking research discoveries, including a dehydrated human cornea and a corneal-derived stem cell stem therapy, from the bench to pre-clinical realisation.  The aim to is create an exciting future portfolio of innovative Biotherapies for NuVision to translate to clinical practice.

During his academic career, Dr Hopkinson has published over 50 scientific papers in leading journals in the fields of ophthalmology and tissue engineering, and has filed four patents.

Lecture Title:
"Advances in Amniotic Membrane Transplantation for Ocular Surface Healing"



Abstracts    

Author

Title

R. Allbaugh

“PREVALENCE AND ANTIBIOTIC SUSCEPTIBILITY OF BACTERIAL ISOLATES FROM HORSES WITH ULCERATIVE KERATITIS IN MIDWESTERN UNITED STATES: MARCH 2014-JUNE 2020”

 

R. Bellone

“WHOLE-GENOME SEQUENCING IDENTIFIES MISSENSE MUTATION IN GRM6 AS THE LIKELY CAUSE OF CONGENITAL STATIONARY NIGHT BLINDNESS IN A TENNESSEE WALKING HORSE”

 

R. Bellone

“A 16 KILOBASE DELETION ON ECA13 IS ASSOCIATED WITH DISTICHIASIS IN FRIESIAN HORSES”

 

E. Crabtree

“PREVENTION OF EXPERIMENTAL AUTOIMMUNE UVEITIS BY INRAVITREAL AAV8-EQUINE-IL10”

 

S. Gesell-May

“GOLDMANN-WITMER COEFFICIENT AND LEPTOSPIRAL PCR IN HORSES WITH CLASSIC ERU AND OTHER DISEASES OR HEALTHY EYES – FIRST RESULTS”

 

H. Hermans

“PENETRATION OF TOPICALLY ADMINISTERED DEXAMETHASONE DISODIUM PHOSPHATE AND PREDNISOLONE ACETATE INTO THE NORMAL EQUINE OCULAR FLUIDS”

 

K. Kline

“EQUINE ENDOTHELIAL IMMUNE MEDIATED KERATITIS IN 21 HORSES (22 EYES): A RETROSPECTIVE STUDY”

 

C. Sheridan

“SURVEY OF OCULAR ABNORMALITIES AND PREVALENCE OF LINEAR KERATOPATHY IN DRAFT HORSES”

 


Case Reports

Author

Title

 

R. Allbaugh

Penetrating Lamellar Keratoplasty with use of Vetrix® BioSIS Plus+ for a Refractory Deep Stromal Abscess

 

H. Hermans

Eosinophilic Keratitis in a Horse Caused by a New Friend

 

M. Huck-Miller

Periorbital Hemangiosarcoma in a Palomino Mare

 

N. La Croix

Meibomian Gland Dysfunction Resulting in Calcification and Osseous Metaplasia in the Meibomian Glands of a Horse

 

A. Lisankis

Primary Corneal Large B Cell Lymphoma in a Horse with Immune-Mediated Keratitis

 

N. Scherrer

Suspected Congenital Horner’s Syndrome